Journal List > Korean J Women Health Nurs > v.25(2) > 1127364

Kim and Kim: Knowledge, Awareness and Risk of Occurrence of Venous Thromboembolism of Perinatal Women

Abstract

Purpose:

The purpose of this study is to identify knowledge, awareness, and risk of occurrence of venous thromboembolism among pregnant women.

Methods:

Subjects were 106 pregnant women treated as inpatients and outpatients at a women's health hospital in a metropolitan city February 19–March 22, 2018. Instruments consisted of questionnaires that included knowledge, awareness, and risk of occurrence of venous thromboembolism queries. Collected data were analyzed by t-test, one-way analysis of variance, Mann-Whitney U test and Kruskal-Wallis test.

Results:

Mean score of subjects' knowledge of venous thromboembolism was 4.47 (0–15), mean score of subjects' awareness of venous thromboembolism was 66.98 (25–100), and mean score of subjects' risk factor of venous thromboembolism was 0.98 (0–44).

Conclusions:

Pregnant women's level of knowledge and awareness of prevention and risk factors on venous thromboembolism, is significantly low. To raise their awareness of risk symptoms and prevent occurrence of the disease, it is essential for nurses as well as medical staffs to: 1) provide an educational program on venous thromboembolism for patients; 2) assess and monitor pregnant women with a risk factor of venous thromboembolism; and 3) implement proper prophylaxis for patients.

REFERENCES

1.Hong J., Lee JH., Yhim HY., Choi WI., Bang SM., Lee H, et al. Incidence of venous thromboembolism in Korea from 2009 to 2013. PLoS One. 2018. 13(1):e0191897.
crossref
2.Korean Statistical Information Service. Health insurance statistics: 298 Salary status by age group by disease classification (total) [Internet]. Daejeon: Korean Statistical Information Service;2017. [cited 2017 Dec 27]. Available from:. http://kosis.kr/statHtml/statHtml.do?orgId=350&tblId=TX_35001_A061.
3.Reardon G., Pandya N., Nutescu EA., Lamori J., Damaraju CV., Schein J, et al. Incidence of venous thromboembolism in nursing home residents. Journal of the American Medical Directors Association. 2013. 14(8):578–584.
crossref
4.James AH., Jamison MG., Brancazio LR., Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. American Journal of Obstetric and Gynecology. 2006. 194(5):1311–1315.
crossref
5.Pillai VG. DVT and pregnancy. Gandhi A, Malhotra N, Malhotra J, Gupta N, Bora NM, editors. editors.Principles of critical care in obstetrics: volume II. Delhi: Springer India;2016. p. 177–195.
6.Bagaria SJ., Bagaria VB. Strategies for diagnosis and prevention of venous thromboembolism during pregnancy. Journal of Pregnancy. 2011. 2011:206858.
crossref
7.Harrington D. Preventing and recognizing venous thromboembolism after obstetric and gynecologic surgery. Nursing for Women's Health. 2013. 17(4):325–329.
crossref
8.Goto M., Yoshizato T., Tatsumura M., Takashima T., Ogawa M., Nakahara H, et al. Safety and efficacy of throm-boprophylaxis using enoxaparin sodium after cesarean section: A multi-center study in Japan. Taiwanese Journal of Obstetrics and Gynecology. 2015. 54(3):248–252.
crossref
9.Heit JA., Spencer FA., White RH. The epidemiology of venous thromboembolism. Journal of Thrombosis and Thrombolysis. 2016. 41(1):3–14.
crossref
10.Guanella R., Ducruet T., Johri M., Miron MJ., Roussin A., Desmarais S, et al. Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. Journal of Thrombosis and Haemostasis. 2011. 9(12):2397–2405.
11.Bonner L., Johnson J. Deep vein thrombosis: diagnosis and treatment. Nursing Standard. 2014. 28(21):51–58.
crossref
12.Almodaimegh H., Alfehaid L., Alsuhebany N., Bustami R., Alharbi S., Alkatheri A, et al. Awareness of venous thromboembolism and thromboprophylaxis among hospitalized patients: a cross-sectional study. Thrombosis Journal. 2017. 15:19.
crossref
13.Alzoubi KH., Khassawneh BY., Obeidat B., Asfoor SS., Al-azzam SI. Awareness of patients who undergo cesarean section about venous thromboembolism prophylaxis. Journal of Vascular Nursing. 2013. 31(1):15–20.
crossref
14.Royal College of Obstetricians & Gynaecologists. Thromboprophylaxis during pregnancy, labour and after vaginal delivery [Internet]. London: RCOG;2004. [cited 2017 Sept 10]. Available from:. http://muppet.pb-works.com/f/Thromboprophylaxis_no037.pdf.
15.Choi DO. Knowledge and care performance of nurses at a local hospital for deep vein thrombosis [master's thesis]. Busan: Dong-A University;2009. p. 60.
16.Yang HJ. Knowledge, health belief, and preventive behavioral intention related to venous thromboembolism (VTE) of the patients with lower limb musculoskeletal disorders [master's thesis]. Gwangju: Chosun University;2013. p. 39.
17.Moon JS. A study of instrument development for health belief of Korean adults [dissertation]. Seoul: Yonsei University;1990. p. 113.
18.Royal College of Obstetricians & Gynaecologists. Reducing the risk of venous thromboembolism during pregnancy and the puerperium: green-top guideline No. 37a [Internet]. London: RCOG;2015. [cited 2017 Sep 10]. Available from:. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37a/.
19.Lee MY., Kim MY., Han JY., Park JB., Lee KS., Ryu HM. Pregnancy-associated pulmonary embolism during the peripartum period: an 8-year experience at a single center. Obstetrics and Gynecology Science. 2014. 57(4):260–265.
crossref
20.Kawaguchi R., Haruta S., Kobayashi H. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux in women at risk after cesarean section. Obstetrics and Gynecology Science. 2017. 60(6):535–541.
crossref
21.Jacobsen AF., Skjeldestad FE., Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium-a register-based case-control study. American Journal of Obstetrics and Gynecology. 2008. 198(2):233. .e1-233.e7. CROSSREF.
crossref
22.Min HY., Jeong GH. Advanced aged women's needs for pregnancy and childbirth care. Korean Journal of Women Health Nursing. 2015. 21(4):332–341. CROSSREF.
crossref
23.Abdul Sultan A., West J., Tata LJ., Fleming KM., Nelson-Piercy C., Grainge MJ. Risk of first venous thromboembolism in pregnant women in hospital: population based cohort study from England. BMJ. 2013. 347:f6099.
crossref
24.Blondon M., Harrington LB., Boehlen F., Robert-Ebadi H., Righini M., Smith NL. Pre-pregnancy BMI, delivery BMI, gestational weight gain and the risk of postpartum venous thrombosis. Thrombosis Research. 2016. 145:151–156.
crossref
25.Liston F., Davies GA. Thromboembolism in the obese pregnant woman. Seminars in Perinatology. 2011. 35(6):330–334.
crossref
26.Virkus RA., Løkkegaard E., Lidegaard Ø., Langhoff-Roos J., Nielsen AK., Rothman KJ, et al. Risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort. PLoS One. 2014. 9(5):e96495.
crossref
27.Le Sage S., McGee M., Emed JD. Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients. Journal of Vascular Nursing. 2008. 26(4):109–117.
crossref
28.Apenteng PN., Fitzmaurice D., Litchfield I., Harrison S., Heneghan C., Ward A, et al. Patients' perceptions and experiences of the prevention of hospital-acquired thrombosis: a qualitative study. BMJ Open. 2016. 6(12):e013839.
crossref
29.O'Connor DJ., Scher LA., Gargiulo NJ 3rd., Jang J., Suggs WD., Lipsitz EC. Incidence and characteristics of venous thromboembolic disease during pregnancy and the postnatal period: a contemporary series. Annals of Vascular Surgery. 2011. 25(1):9–14.
30.Bayrampour H., Heaman M., Duncan KA., Tough S. Advanced maternal age and risk perception: a qualitative study. BMC Pregnancy and Childbirth. 2012. 12:100–112.
crossref

Table 1.
General Characteristics of the Subjects (N=106
Characters Categories n(%) M±SD
Age (year) 25–29 14 (13.2) 34.39±3.66
  30–34 55 (51.9)  
  ≥35 37 (34.9)  
Religion Yes 45 (42.5)  
  No 61 (57.5)  
Level of education High school 12 (11.3)  
  College/university 83 (78.3)  
  Graduate school 11 (10.4)  
Job Yes 34 (32.1)  
  No 72 (67.9)  
Type of pregnancy Natural pregnancy 101 (95.3)  
  Test tube pregnancy 5 (4.7)  
Pre-pregnancy BMI (kg/m2) <25 96 (90.6) 21.29±2.94
  ≥25 10 (9.4)  
Current BMI (kg/m2) <25 59 (55.7) 25.17±3.68
  ≥25 47 (44.3)  
Smoking Yes 3 (2.8)  
  No 103 (97.2)  
Multiple pregnancy Singleton 103 (97.2)  
  Twins 3 (2.8)  
Previous experience of abortion Yes 28 (26.4)  
  No 78 (73.6)  
Previous experience of delivery (number) 0 56 (52.8)  
  1 30 (28.3)  
  ≥ 2 20 (18.9)  
Type of pregnant woman Gravida 66 (62.3)  
  Parity 40 (37.7)  
Gestation week (weeks)     28.17±6.75
Type of delivery Vaginal delivery 21 (52.5)  
Previous admission history during pregnancy Cesarean delivery Yes 19 (47.5) 18 (17)  
  No 88 (83)  
Chronic disease Yes 5 (4.7)  
  No 101 (95.3)  
Previous experience of hearing on VTE Yes 24 (22.6)  
  No 82 (77.4)  

M±SD=mean±standard deviation; BMI= body mass index; VTE=venous thromboembolism.

Respondents of gravida (N=66);

Respondents of parity (N=40).

Table 2.
Degree of Knowledge and Awareness for VTE (N=106)
Variables Total score and subcategory scores M±SD Score range
Knowledge of VTE Total score 4.47±4.29 0–15
  Understand and risks 0.46±0.86 0–3
  Symptom 0.73±0.99 0–3
  Diagnosis 0.35±0.66 0–2
  Prevention and treatment 2.93±2.50 0–7
Awareness of VTE Total score 66.98±6.99 25–100
  Perceived sensitivity 11.70±2.16 5–20
  Perceived severity 12.58±2.64 5–20
  Perceived benefit 15.08±2.30 5–20
  Perceived disability 11.56±1.86 5–20
  Health motive 16.16±2.50 5–20

M±SD=mean±standard deviation; VTE=venous thromboembolism.

Table 3.
Difference between Knowledge and Awareness for VTE by Subject Characteristics (N=106)
Characteristics Categories   Knowledge     Awareness  
    M±SD t/F/Z p M±SD t/F/Z p
Age (year) 25–29 6.79±5.48 2.45 .091 67.14±7.67 0.02 .976
  30–34 4.22±4.23     66.84±6.40    
  ≥35 3.97±3.67     67.14±7.74    
Level of education High school 3.67±4.29 0.62 .542 63.58±11.75 2.03 .136
  College/university 4.43±4.33     67.18±6.20    
  Graduate school 5.64±4.06     69.18±5.23    
Type of pregnant woman Gravida 3.76±3.92 −2.25 .027 67.83±6.15 1.62 .107
  Parity 5.65±4.66     65.58±8.08    
Previous experience of delivery (number) 0 3.71±3.90 2.40 .096 67.96±6.20 1.18 .312
  1 4.83±4.52     65.87±8.42    
  ≥2 6.05±4.70     65.90±6.99    
Type of delivery Vaginal delivery 5.33±4.90 −0.63 .531 65.76±9.81 −0.11 .913
  Cesarean delivery 6.00±4.47     65.37±5.87    
Previous surgical experience history Yes 5.39±4.33 1.31 .194 67.00±4.94 <0.01 1.000
  No 4.18±4.24     67.00±7.67    
Chronic disease Yes 6.40±4.83 1.03 .305 67.20±3.42 0.07 .943
  No 4.38±4.26     66.97±7.13    
Previous experience hearing on VTE Yes 7.75±4.97 3.89 .001 69.46±5.26 2.00 .048
  No 3.51±3.56     66.26±7.29    
Pre-pregnancy BMI (kg/m2) <25 4.63±4.31 1.14 .256 67.20±6.94 0.99 .325
  ≥25 3.00±4.03     64.90±7.51    
Current BMI (kg/m2) <25 4.51±4.28 0.10 .922 67.88±5.78 1.49 .138
  ≥25 4.43±4.34     65.85±8.19    
Smoking Yes 2.00±1.73 −1.01 .313 67.00±6.08 0.01 .996
  No 4.54±4.32     66.98±7.05    
Religion Yes 5.27±4.52 1.65 .101 66.78±6.81 −0.26 .798
  No 3,89±4.05     67.13±7.18    
Job Yes 4.91±3.67 0.72 .470 67.97±8.19 1.00 .319
  No 4.26±4.56     66.51±6.32    
Multiple pregnancy Singleton 4.47±4.31 −0.08 .937 67.03±7.06 0.41 .681
  Twins 4.67±4.16     65.33±4.51    
Type of pregnancy Twins Natural pregnancy 4.67±4.16 4.46±4.35 −0.18 .862 65.33±4.51 66.95±7.07 −0.20 .840
  Test tube pregnancy 4.80±3.03     67.60±5.77    
Previous admission history during pregnancy Yes 4.00±4.06 0.51 .611 69.83±6.24 −1.92 .057
  No 4.57±4.35     66.40±7.03    

M±SD=mean±standard deviation; BMI=body mass index; VTE=venous thromboembolism.

Mann-Whitney U test.

Table 4.
Degree of Risk of Occurrence for VTE by Subjects (N=106)
Variables Subarea M±SD Score range
Risk of occurrence Total score 0.98±0.97 0–44
  Pre-existing risk factors 0.50±0.62 0–21
  Obstetric risk factors 0.29±0.62 0–11
  Transient risk factors 0.18±0.39 0–12

M±SD=mean±standard deviation; VTE=venous thromboembolism.

Table 5.
Frequency of Risk Factors for VTE by Subjects (N=106)
Risk factors for VTE n(%)
Pre-existing risk factors 1. Previous VTE (except a single event related to major surgery) 0 (0.0)
2. Previous VTE provoked by major surgery 0 (0.0)
3. Known high-risk thrombophilia 0 (0.0)
4. Medical comorbidities, e.g., cancer, heart failure; active systemic lupus erythematosus, 0 (0.0)
inflammatory polyarthropathy or inflammatory bowel disease; nephrotic syndrome; type I diabetes mellitus with nephropathy; sickle cell disease; current intravenous drug user 5. Family history of unprovoked or estrogen-related VTE in first-degree relative 0 (0.0)
6. Known low-risk thrombophilia (no VTE) 0 (0.0)
7. Age (≥35 years) 36 (34.0)
8. Obesity 11 (10.4)
9. Parity ≥3 3 (2.8)
10. Smoker 3 (2.8)
11. Gross varicose veins 0 (0.0)
Obstetric risk factors  
12. Pre-eclampsia in current pregnancy 0 (0.0)
13. ART/IVF (antenatal only) 5 (4.7)
14. Multiple pregnancy 3 (2.8)
15. Caesarean section in labour 5 (4.7)
16. Elective caesarean section 14 (13.2)
17. Mid-cavity or rotational operative delivery 0 (0.0)
18. Prolonged labour (≥24 hours) 0 (0.0)
19. PPH (>1 litre or transfusion) 0 (0.0)
20. Preterm birth <37+0 weeks in current pregnancy 1 (0.9)
21. Stillbirth in current pregnancy 0 (.00)
Transient risk factors  
22. Any surgical procedure in pregnancy or puerperium except immediate repair of the 0 (0.0)
perineum, e.g., appendicectomy, postpartum sterilisation  
23. Hyperemesis 1 (0.9)
24. OHSS (first trimester only) 0 (0.0)
25. Current systemic infection 0 (0.0)
26. Immobility, dehydration 18 (17.0)

ART=assisted reproductive technology; IVF=in vitro fertilisation; OHSS=ovarian hyper-stimulation syndrome; VTE=venous thromboembolism.

TOOLS
Similar articles